SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on December 6, 2024, reporting an event that occurred on December 3, 2024. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a legal matter and contains no financial performance data.
Material Changes and Legal Developments
The filing addresses the resolution of a lawsuit filed on March 22, 2024, by Michael Gray Fleming against the Company, its former CEO, and former CFO. The plaintiff alleged a failure to issue stock under a restricted stock award agreement, seeking at least $288,000 in damages. On December 3, 2024, the Hennepin County, Minnesota District Court issued an Order Granting Motion to Dismiss the plaintiff's claims.
Outlook, Risks, and Management Commentary
Management previously characterized the allegations as baseless. The dismissal of the lawsuit removes the specific contingency regarding the $288,000 potential liability. No forward-looking guidance or new risk factors were disclosed in this specific filing.
Investor Verification Checklist
- Verify the finality of the court order and whether the plaintiff has filed an appeal.
- Confirm the current status of the restricted stock award agreement in question.
- Review recent 10-K or 10-Q filings for the company's actual financial position, as this 8-K contains no financial data.
- Check for any other pending litigation involving the former CEO or CFO.